HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease (Q44633043)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2003
edit
Language Label Description Also known as
English
HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease
scientific article published in October 2003

    Statements

    HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit